Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution

Bratislava Medical Journal

Volumn 109, Issue 7, 2008, Pages 324-328

  Palagyi, Michaela ^a   Lassanova, M ^b  

^a The Slovak Generic Association (GENAS)   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

GENAS; Generic association; Generic drug; Information about generics

Indexed keywords

GENERIC DRUG;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT; PHARMACOKINETICS; PSYCHOLOGICAL ASPECT; SLOVAKIA;

ADULT; AGED; ATTITUDE TO HEALTH; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENTS; SLOVAKIA; THERAPEUTIC EQUIVALENCY;

EID: 57049151854     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Directive 2004/27/EC of The European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, Article 10., Official Journal of the European Union L 136/34. Available at: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/ dir_2004_27/dir_27_en-pdf. Accessed September 23, 2007.
2. Note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98. London: EMEA, 2001: 3-11. Available at: http://.emea.europa.eu/pdfs/human/ewp/140198en-pdf. Accessed September 23, 2007.
3. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000. Ann Intern Med. 2005; 142: 891-897.
4. Kreling DH, Mott DA, Wiederholt JB. Prescription Drug Trends: A Chartbook Update. Menlo Park, California: Henry J. Kaiser Family Foundation, 2001. Available at: http://www.kff.org/rxdrugs/ loader-cfm?url=/commonspot/security/getfile.cfmPagel D=13796. Accessed September 11, 2007.
5. Primer A. Generic drugs, patents and the pharmaceutical marketplace [document on the internet]. National Institute for Health Care Management Foundation; 2002. Available at: http://www.nihem.org/ -nihcmor/pdf/GenericsPrimer.pdf. Accessed September 23, 2007.
6. Andersson K, Bergström G, Petzold MG, Carlsten A. Impact of a generic substitution reform on patients? and society's expenditure for pharmaceuticals. Health Policy 2007; 81: 376-384.
7. Vyhláška Ministerstva zdravotníctva Slovenskej republiky è. 559/2005 Z.z., ktorou sa ustanovuje zoznam ATC skupín liekov, pri ktorých je moYný výdaj náhradného generického lieku, úèinnos?15 Dec 2005. [Decree of Ministry of Health in The Slovak republic No. 559/2005 laying down the list of medicinal products in ATC groups, where a generic substitution could be performed, came into force 15 Dec 2005]. Available at:. Accessed September 23, 2007.
8. IMS dataview 6.7 - Slovak combined DataView Database June 2007, YTD/05/07. 2003 IMS Health Incorporated.
9. Kjoenniksen I, Lindbaek M, Granas AG. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006; 28: 284-289.
10. Brennan TA, Lee TH. Allergic to generics. Ann Intern Med 2004; 141: 126-130.
11. Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA et al. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med 2004; 164: 427-432.
12. Himmel W, Simmenroth-Nayda A, Niebling W et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43: 472-479.
13. Mott DA, Cline RR. Exploring generic drug use behaviour: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002; 40: 662-674.
14. Zákon NR SR è. 140/1998 Z.z. o liekoch a zdravotníckych pomôckach, §38b [Act of The National Council of The Slovak republic No. 140/1998 relating to medicinal products and medical devices, paragraph 38. Available at: http://www.zbierka.sk/zz/predpisy/ default.spx?PredpisID=14397FileName=98-z140Rocnik=1998. Accessed September 23, 2007.
15. Murphy JE. Generic substitution and optimal patient care (Editorial). Arch Intern Med 1999; 159: 429-433.
16. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003; 25: 2875-2890.
17. Sagardui-Villamor JK, Lacalle Rodríguez-Labajo M, Casado-Buendía S. Substitution of generic for brand medicines in primary care. Factors associated to refuse change. Aten Primaria. 2005; 36: 489-493.
18. Honrubia AF, Carbajal de Lara JA, Cebrian Picazo C et al. Acceptance of replacement by generic medicines at community pharmacies. Aten Primaria 2007; 39: 81-85.